根据中国血友之家的统计,2015年我国大陆地区甲型血友病患病人数约为12000人。以12000患者、每人每年预防治疗用药量300瓶计算,我国大陆地区人凝血因子Ⅷ产品的需求量约为360万瓶,而目前产量仅为80~90万瓶,远不能满足患者人数以及用药需求的增长。为解决甲型血友病患者的基本用药,自2008年国家 According to the statistics of China’s Heiou You House, in 2015, the number of patients with Hemophilia A in mainland China was about 12,000. With 12,000 patients, prevention and treatment of drugs per person per year 300 bottles of calculation, the demand for human coagulation factor Ⅷ products in mainland China is about 3.6 million bottles, while the current output of only 80 to 900,000 bottles, far from meeting the patient number and medication Demand growth. To solve the basic medication for patients with hemophilia A, since 2008 the country